National Plan to Address Alzheimer's Disease

National Plan establishes six ambitious goals to both prevent future cases of Alzheimer's disease and related dementias (AD/ADRD), and to better meet the needs of the millions of American families currently facing this disease.

Prevent and Effectively Treat AD/ADRD by 2025.
Enhance Care Quality and Efficiency.
Expand Supports for People with AD/ADRD and Their Families.
Enhance Public Awareness and Engagement.
Improve Data to Track Progress.
Accelerate Action to Promote Healthy Aging and Reduce Risk Factors for AD/ADRD.

May and June 2022 mark the 10th Anniversary of the National Plan to Address Alzheimer’s Disease, the federal strategy for reducing the burden of AD/ADRD by accelerating research towards treatments, improving care and support for people facing these conditions now, and reducing the risk of AD/ADRD by promoting brain health. Below are a list of pages celebrating how far federal agencies have come in the past several years, in addition to the original National Plan and the yearly updates.

NAPA and the Advisory Council invite the public to submit comments on the Advisory meetings, NAPA and its National Plans, or issues involving AD/ADRD. Emails can be sent to napa@hhs.gov which will be shared with the Advisory Council. NOTE: Emails considered threatening or offensive, or found to be spam, will not be included in the online Public Comments. Slight editing may be necessary when included, but email context will not be changed.
Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.

National Plan 2026 Update

To inform the 2026 update to the National Plan to Address Alzheimer's Disease, the U.S. Department of Health and Human Services (HHS) is providing opportunities for public input through listening sessions and a Request for Information (RFI). These opportunities invite input from people living with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD), family members, caregivers and care partners, researchers, clinicians, service providers, advocates, policymakers, and other interested stakeholders to help inform the comprehensive update to the National Plan.

National Plan to Address Alzheimer's Disease